Abstract
The best therapy regimen for refractory obstetrical antiphospholipid syndrome remains to be determined. Additional treatments with steroids, plasma exchanges and immunoglobulins failed to show any beneficial effect. We present a case of a woman who had a better pregnancy outcome after the administration of hydroxychloroquine (HCQ) as additional treatment. Furthermore, we highlighted that HCQ was able to dramatically reduce the antiphospholipid antibodies levels.
| Original language | English |
|---|---|
| Pages (from-to) | 760-762 |
| Number of pages | 3 |
| Journal | Autoimmunity Reviews |
| Volume | 14 |
| DOIs | |
| Publication status | Published - 2015 |
Keywords
- Antibodies, Antiphospholipid
- Antiphospholipid Syndrome
- Hydroxychloroquine
- Pregnancy
- Pregnancy Complications
- Pregnancy Outcome
Fingerprint
Dive into the research topics of 'Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver